We are live on
!
Find out more
NP
Newlight Partners Portfolio holdings
AUM
$3.9M
1-Year Est. Return
96.05%
This Fund
S&P 500
This Quarter
Est. Return
-17.77%
1 Year Est. Return
-96.05%
3 Year Est. Return
-92.84%
5 Year Est. Return
-96.09%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
-$387M
(-14%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
10.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OWL
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Biosciences
HRMY
|
+$24.7M |
| 2 |
Laureate Education
LAUR
|
+$3.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.76% |
| 2 | Financials | 12.95% |
| 3 | Technology | 9.28% |
| 4 | Consumer Staples | 0.01% |
Similar funds
BPWM
TCP
CP
CCM
HIP
AI
CAWM
ADIM
Newlight Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Newlight Partners held 5 positions worth $2.31B, down 14% from $2.7B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Newlight Partners deployed $239M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was Blue Owl Capital: 19,220,989 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 91% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Harmony Biosciences, an estimated $24.7M trimmed.
- Newlight Partners's largest Q3 2021 buy was Blue Owl Capital: 19,220,989 shares worth $299M.
- Newlight Partners's biggest Q3 2021 reduction was Harmony Biosciences, cutting an estimated $24.7M.
- Newlight Partners's ten largest holdings make up 100% of its $2.31B portfolio in Q3 2021.
- Newlight Partners opened 1 new position and closed 0 in Q3 2021.
- Newlight Partners's portfolio value fell 14% quarter-over-quarter to $2.31B.
Based on Newlight Partners's 13F filing for Q3 2021, filed 15 Nov 2021.